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Treatment of advanced renal failure: Low-protein diets or maintenance dialysis [8, 9]. In this article, we present a
timely initiation of dialysis? Until 1996, no guidelines existed critical review of the data that have accumulated in this
for the initiation of dialysis in patients with progressive renal field since the time of our last review [6], and we re-failure. The publication of the National Kidney Foundation-
emphasize some of the old data in light of the criticismDialysis Outcome Quality Initiative guidelines has generated
of our position. For the purposes of this article, we usea debate on the management of advanced renal failure and
the role of low-protein diets (LPDs). We performed a review the term advanced renal failure for patients with a weekly
of the literature to identify articles on the initiation of dialysis renal Kt/Vurea ,2.0, the level of renal function at whichand LPDs, particularly those since 1996. Delayed referral of
the Peritoneal Dialysis Subcommittee of the Nationalpatients is widespread in both the United States and Europe,
Kidney Foundation-Dialysis Outcome Quality Initiativeand almost 25% of patients are started on dialysis at a glomeru-
lar filtration rate (GFR) of ,5 mL/min/1.73 m2. There is a high (NKF-DOQI) recommended consideration of initiation
prevalence of malnutrition at the time of first dialysis, which of dialysis [10].
progressively improves upon initiation of dialysis. There is no
evidence regarding the efficacy or safety of LPDs in nondiabetic
patients younger than 70 years old [approximately 40% of U.S. CURRENT PRACTICE OF INITIATION
incident end-stage renal disease (ESRD) patients] and in diabet-
OF DIALYSISics with GFR ,25 mL/min/1.73 m2 (.40% of incident U.S.
ESRD). In nondiabetics who are younger than 70 years old, Over the last two years, more information has accumu-
adherence to LPD for four to five years can be estimated lated about the level of renal function at the time of
to result in a delay in dialysis by 6 to 11 months. However,
initiation of dialysis. As suspected, delayed referral issuboptimal energy intake is widespread in advanced renal fail-
widespread in both the United States and Europeure, which declines further upon institution of LPD. Even
nutritionally sound patients develop subclinical nutritional de- [11, 12]: About one third of incident end-stage renal
cline despite intense counseling. There are no data on the disease (ESRD) patients are referred to a nephrologist
efficacy or safety of LPD in subgroups that constitute approxi- less than one month prior to the initiation of chronic
mately 80% of incident ESRD patients. Concerns still exist
dialysis. Moreover, average small solute clearances atregarding their nutritional safety in the remainder. Initiation
which patients are started on renal replacement therapyof dialysis results in improved nutritional status and should be
considered in a timely fashion. are significantly lower than the current adequacy stan-
dards for dialysis (abstract; Jansen et al, J Am Soc
Nephrol 9:212A, 1998) [10, 12–16], and only a tiny frac-
In the last four years, the management of advanced tion of patients start dialysis at levels above those recom-
renal failure has become a subject of intense controversy. mended by the NKF-DOQI. At a single U.S. center, only
While some have argued in favor of a timely initiation 4% of patients started dialysis at an estimated glomerular
of dialysis [1–7], others have argued in favor of continued filtration rate (eGFR) of .10.5 mL/min/1.73 m2 between
dietary protein restriction at levels of small solute clear- 1994 and 1996 [13]. At two different centers in the north-
ances far below the adequacy targets for patients on east, 35 and 24% of patients started dialysis at an eGFR
of ,5 mL/min/1.73 m2 [13, 14]. More recently, data on
90,897 patients who began dialysis in the United StatesKey words: hemodialysis, CAPD, nutrition, malnutrition, progressive
renal disease, kidney dialysis, end-stage renal disease. between April 1995 and September 1997 have been pub-
lished, confirming the previous small center observa-
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practice is no different in Europe. In a survey of 18 LOW-PROTEIN DIETS IN PATIENTS WITH
ADVANCED RENAL FAILUREnephrology units in seven European countries during
1996 and 1997, while only 18% started dialysis at a creati- The early days of chronic dialysis were characterized
nine clearance of .10 mL/min, 34% started dialysis at by limited availability of the technique, challenges with
a creatinine clearance of ,5 mL/min [12]. The latter access, limited understanding of the concept of minimal
versus adequate or optimal dialysis and uncertain reim-study also confirmed the well-known negative health im-
bursement. Carefully conducted studies confirmed thepact of delayed referral, while this and another study re-
beneficial effect of low-protein diets (LPDs) on uremicemphasized the negative economic impact [12, 17]. Three
symptoms and metabolic acidosis [27, 28], and hence,observational studies have demonstrated a higher mor-
they were introduced in clinical practice to forestall dial-bidity and mortality in patients who start dialysis at lower
ysis. However, even today, some recommend continuedlevels of renal function [3, 18, 19], and hence, it is proba-
protein restriction even when the creatinine clearanceble, although not known, that the current practice of
declines to below 5 mL/min [29]. Initiation of chronicdelayed initiation of dialysis may contribute to the high
dialysis is as successful in ameliorating the symptomsmortality rate of maintenance dialysis patients.
and the metabolic abnormalities associated with uremia,The initiation of dialysis at such low levels of small
and we are of the opinion that initiation of renal replace-
solute clearance is often associated with evidence of mal-
ment therapy with less restricted diets is a better strategy
nutrition. In an analysis of 110,843 patients who started than LPDs. Hence, we do not support LPDs only for
dialysis in the United States between April 1995 and the sole purpose of forestalling dialysis.
June 1997, 67% of patients had a serum albumin ,3.5 There has been a resurgence of interest in LPDs after
g/dL at the time of their first dialysis, and the prevalence animal studies suggested a role for protein restriction in
increased by 2% each year during the study period [20]. slowing the progression of renal failure. Given the increas-
This prevalence was higher than the 50% prevalence ing burden of ESRD on society, a therapeutic interven-
within two to six weeks of start of dialysis for incident tion that purports to slow the progression of renal failure
patients in 1986 to 1987 [21], which is extremely concern- needs intense scrutiny, and its cost-efficacy needs to be
ing, as hypoalbuminemia at the time of initiation of dial- determined. The importance of blood pressure control
ysis is a strong predictor of mortality for at least the first and angiotensin-converting enzyme inhibitor (ACEI)
five years on dialysis [22]. A detailed assessment of nutri- therapy in patients with progressive renal failure is well
established and, hence, clearly cost-effective, and in pa-tional status of 37 patients from Singapore, who started
tients with diabetes mellitus, strict glycemic control meetsdialysis at a renal urea clearance significantly lower than
the same standards. However, does institution of LPDsthat recommended by DOQI, is in agreement with the
meet the same standards? In this section, we restrict ourfindings from the CANUSA study that there is a high
discussion to patients with advanced renal failure andprevalence of malnutrition in patients at the time of
attempt to answer three important questions: Do LPDsinitiation of chronic dialysis [23, 24]. These studies sug-
slow progression of nondiabetic and diabetic renal fail-gest that malnutrition among the prevalent dialysis pa-
ure, and if yes, what is the magnitude of effect? Willtients antedates the initiation of renal replacement ther-
the diet maintain the nutritional status of both of theseapy and early identification of malnutrition, and timely
groups of patients? Finally, what are the current re-intervention should constitute an important aspect of
sources available to implement this strategy, and will itpre-ESRD care.
be cost-effective?To date, little is known about the trends in initiation
of dialysis. The progressive decline in serum creatinine Slowing progression of renal failure
at the time of initiation of dialysis over several years has
Nondiabetic renal disease. We have reviewed several
been interpreted by some as a trend toward initiation aspects of this issue in detail elsewhere [2, 5, 6], and
of dialysis at higher levels of small solute clearances here, we limit our critique to only those studies that
(abstract; Young et al, J Am Soc Nephrol 6:569, 1995) evaluated the role of LPDs in patients with advanced
[15, 25]. However, a recent analysis of data from the renal failure and used a reliable method to measure
Health Care Financing Administration (HCFA) Medical GFR. To the best of our knowledge, there are no ran-
Evidence Form (2728) submitted to ESRD Network 5 domized controlled trials (RCTs) of LPDs in patients
has seriously questioned this interpretation [26], and with GFR ,10.5 mL/min. In this section, thus, we confine
points to the fact that the declining serum creatinine is our comments to the Modification of Diet in Renal Dis-
more likely a result of a greater frequency of diabetics ease (MDRD) definition of advanced renal failure: A
and older patients among the incident cohort. Hence, GFR between 13 and 24 mL/min/1.73 m2. Several RCTs
and three meta-analyses have evaluated the effect ofwe still await encouraging trends in this regard.
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LPD on the rate of decline in GFR at this level of renal leads to an initial steep decline in GFR (as noted in
patients in study A) and a subsequent long-term slowingfunction in nondiabetic patients (abstract 29; Cockram
et al, 7th Int Congr Nutr Metabol Renal Dis, 1994) [30–36]. in the rate of decline of renal function. Institution of
LPD in study B was not associated with the initial steepThree of these studies did not have a control group
with usual protein intake (abstract; Cockram et al, 1994) decline in GFR. Can this be interpreted to mean as the
absence of a favorable hemodynamic response to LPD[31, 33] and one of these is available only in an abstract
form. Hence, these are not reviewed. Furthermore, as in patients with advanced renal failure, or was it a result
of a much smaller change in dietary protein intake (DPI;the meta-analysis by Fouque et al did not include any
study of LPDs in patients with advanced renal failure mean of 0.84 to 0.89 g/kg/day at baseline to 0.65 to 0.73
g/kg/day upon follow-up) or both? In either case, it ap-[34] and that of Pedrini et al included only one [35],
their results are not applicable to our current discussion. pears that the magnitude of spontaneous decline in DPI
has been underappreciated by the proponents of proteinMoreover, we have already expressed concern about use
of “renal death” as an end-point for evaluating the role restriction, and we wonder whether these data mean that
in face of a spontaneous decline in DPI, introduction ofof LPD in disease progression given the confounding
influence of symptom amelioration in such an analysis LPD does not produce a significant change in glomerular
hemodynamics. We do not have answers for these ques-[6]. This leaves us with only two RCTs and one meta-
analysis of LPDs in patients with advanced renal failure. tions, but clearly, the argument that a longer follow-up
may show a beneficial effect is less persuasive in patientsBoth of these trials excluded patients over the age of
70. It is to be noted that between 1994 and 1997, 39% with advanced renal failure. Second, the rate of decline
in renal function in patients enrolled in study B (4 mL/of nondiabetic incident ESRD patients in the United
States were over the age of 70 [15]. The nutritional needs min/year) was identical to that in patients eating an usual
protein diet enrolled in study A (4 mL/min/year) [32].of older patients on dialysis are currently unknown but
are suspected to be different from that of younger pa- This information, however, does not permit us to draw
any conclusions about the impact of LPD on the ratetients. Similarly, to date, no data are available on the
efficacy of LPD in patients over the age of 70. Ihle et al of disease progression in patients with advanced renal
failure.randomized 64 patients with moderate to severe renal
failure (ages 19 to 69) to receive either an unrestricted Given the design of study B, we are forced to depend
on the secondary, post hoc analysis to determine the(at least 0.75 g/kg/day) or a LPD (prescribed 0.4 g/kg/
day, achieved approximately 0.7 g/kg/day) [30]. They do effect of protein restriction, the results of which cannot
be considered conclusive. Using correlational analysisnot provide any slope data, but from the data provided,
it can be deduced that over an 18-month period, while of achieved rather than prescribed protein intake, the
authors conclude that in patients with advanced renalthe renal function declined at the rate of 6 mL/min/year
in the control group, it declined at the rate of 1.2 mL/ failure, a decline in DPI by 0.2 g/kg/day will result in a
1.15 mL/min/year less steep decline in the mean GFRmin/year in the LPD group. The magnitude of effect
appears large, but it is unclear whether this was statisti- slope [37]. What is the clinical significance of this obser-
vation? We shall restrict our analysis to the LPD group,cally significant. The other end points that they reported
are essentially flawed. Serum creatinine declines upon as keto acids are unavailable at least in the United States,
and hence, very-low protein diets (VLPDs), as used ininstitution of LPD, and symptom amelioration con-
founds the interpretation of “renal death” [30]. the MDRD study, cannot be currently prescribed. De-
spite intensive nutritional counseling, patients enrolledThe results of the National Institutes of Health-spon-
sored MDRD study were published in 1994 [32]. Our in study B could decrease their DPI from a mean of
approximately 0.86 g/kg/day at baseline to approximatelyprevious publications have pointed out the inconclusive
results of the MDRD study [2, 5, 6]. It should be noted 0.72 g/kg/day, a decline of 0.14 g/kg/day [38]. It is unlikely
that in clinical practice a greater decline in DPI is feasi-again that the age range of patients enrolled in this study
was 18 to 70 years. Here, we present a detailed critique ble. This translates into a slowing of the rate of decline
of GFR by 0.81 mL/min/year, a value 50% higher thanof study B, the study of LPD in patients with a baseline
GFR of 13 to 24 mL/min/1.73 m2 [32]. Unfortunately, that obtained from the meta-analysis of Kasiske et al
[36]. Assuming a baseline rate of progression of 4the design of the study does not permit us to answer the
question at hand, do LPDs have an advantage over the mL/min/year (the rate in patients in MDRD study A on
usual protein diet), a linear loss of function, a constantusual protein diet in slowing the rate of decline of GFR,
as there was no control group with the usual protein in- compliance and effect of treatment over time, and assum-
ing that dialysis will be initiated at a GFR of 10.5 mL/min,take. However, we raise two interesting questions about
the primary intention-to-treat analysis. First, the proposed if a patient starts with a GFR of 25 mL/min, adherence to
a LPD for 4.5 years will delay dialysis by either 11 monthsbeneficial effect of LPDs is thought to be dependent on
a favorable alteration in glomerular hemodynamics, which (MDRD data) or by 6 months (Kasiske et al data). No
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definitive conclusions can be made about the validity of associated with nutritional decline [48] and as reviewed
earlier, a large proportion of patients start dialysis alreadysuch a post hoc analysis. Even if we were to accept these
conclusions as suggestive, while at first glance forestalling malnourished [23, 24], it is imperative that any therapy that
we institute in the pre-ESRD phase is nutritionally safe.dialysis for 6 to 11 months may appear to be an attractive
goal, three important issues need to be addressed: Is this Nondiabetic renal disease. We have recently reviewed
the data regarding the safety of long-term use of LPDssmall effect of LPDs demonstrable in patients already
on an ACEI therapy? Is the approach nutritionally safe? in nondiabetic renal disease [6]. Let us point out again
that to the best of our knowledge, there are no short- orIs it feasible to implement LPDs on a large scale, and
will it be cost-effective? Finally, which strategy results long-term data available on the safety of these diets in
patients over the age of 70 years. As the older populationin an improved quality of life (QOL) in patients with
advanced renal failure: LPDs for at least 4 to 5 years to is more vulnerable to malnutrition, at this time, LPDs
should probably not be prescribed to the older patients.gain 6 to 11 months free of dialysis or initiation of dialysis
with unrestricted DPI? We present here a brief overview of our concerns of
LPDs in patients with advanced renal failure and presentWhile no patient in the study by Ihle et al was on ACEI,
the MDRD study was not designed to study whether the data published since our last review of this issue.
The evidence in support of the safety of LPDs has re-benefits of LPD and ACEI were additive. ACEI and
LPD are purported to work through a favorable alter- cently been extensively reviewed [8, 9, 49, 50]. There are
good data to suggest that the dietary energy and proteination of glomerular hemodynamics. It is probable, al-
though not known, that LPDs may have little or no requirements of patients with chronic renal failure are
identical to that of healthy controls, and these patientseffect in the presence of ACEI therapy. This question,
however, remains unanswered but is of immense impor- have the ability to activate the normal adaptive mecha-
nisms (suppression of amino acid oxidation and post-tance. Drug therapy, although not without risks, is clearly
less labor intensive and results in significantly less alter- prandial inhibition of protein degradation) in face of
LPD [51–53]. Moreover, we do not argue with the abilityation in lifestyle than a LPD without the associated nutri-
tional concerns. of LPD to maintain neutral nitrogen balance in these
patients as long as there is an adequate total energy in-Diabetic renal disease. The data regarding the efficacy
of LPD in patients with diabetic nephropathy are more take (35 kcal/kg/day), absence of metabolic acidosis and
a high proportion (.50%) is of high biologic value. How-limited than in nondiabetic renal disease: No more than
200 patients with diabetic nephropathy have been evalu- ever, our concerns stem from the difficulty in achieving
an adequate energy intake in the face of dietary proteinated [35, 36, 39]. To the best of our knowledge, there are
no data regarding their efficacy in diabetic patients with restriction [6]. The inability to maintain an energy intake
of 35 kcal/kg/day in patients on 0.6 g/kg/day proteina GFR ,10.5 mL/min. Furthermore, there is no RCT
evaluating their efficacy in patients with a GFR of 13 to diets puts patients at risk of catabolizing their own body
protein stores [49, 54]. The importance of energy intake24 mL/min/1.73 m2. Only one center has published the
results of an observational study in 32 patients using a in the face of protein restriction has been underscored
by recent evidence that LPDs may actually raise energyvegetarian LPD supplemented by keto acids, creatinine
clearance as a measure of GFR, and the prestudy period production rates [55]. It is likely that in face of an
achieved DPI of approximately 0.7 g/kg/day in patientsas a control [39]. The evidence in advanced diabetic neph-
ropathy, thus, is weak. Moreover, the currently available prescribed LPD [38], the energy requirements are
slightly lower but are likely to be at least 30 kcal/kg/day.data do not permit us to compare the spontaneous DPI
in patients with advanced renal failure with prescribed Four studies, other than the MDRD, are frequently
cited as evidence for the long-term safety of LPDs inand achieved intake in patients on a LPD. Hence, we are
unable to comment on the clinical significance of the effect patients with advanced renal failure [52, 56–58]. A fifth
has since been published [59]. The patients enrolled inof LPD in diabetic patients with a GFR of ,25 mL/min.
Finally, less than 10% of patients enrolled in these stud- these studies had a baseline GFR of ,20 mL/min. All
of these studies were performed at single centers withies were treated with an ACEI. In an age when ACEIs
form the cornerstone of therapy in patients with diabetic considerable experience and expertise in the use of these
diets, and all, except one [58], were small with an averagenephropathy, we do not have any data that suggest that
LPDs have a beneficial effect in face of ACEI therapy. of 10 patients (range of 6 to 15) [52, 56, 57, 59]. It is
likely that the patients were also highly motivated and
Nutritional safety in all studies, except one [52], achieved an energy intake
that exceeded 30 kcal/kg/day. In the latter study, patientsIt is now well established that malnutrition at the time
of initiation of chronic dialysis is a strong predictor of sub- were unable to increase their energy intakes despite nu-
tritional counseling. On these LPDs, neutral nitrogensequent mortality and morbidity of patients on mainte-
nance dialysis [24, 40–47]. As progressive renal failure is balance was maintained [52, 56, 57]. There was a small
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but significant increase in serum albumin [56–58], while diabetic patients, and no short-term balance studies are
serum transferrin increased slightly [56] or was unchanged available for the younger diabetics with advanced renal
[52, 57–59]. Body weight remained unchanged in two of failure. The only long-term study involved 32 patients
these studies [52, 59]; however, in the largest of these with an average age of 44 years, a mean follow-up of 3.7
studies, body weight declined at the rate of 0.14 kg/month years, and an energy intake of .30 kcal/kg/day [39]. In
[58]. If the latter data are reproduced and this weight conjunction with an adequate energy intake, the LPD
loss is sustained, it would mean almost a 10% decline in remained nutritionally safe.
weight in a 70 kg person over the five-year period of protein
Feasibility and cost-effectiveness of LPDsrestriction necessary to forestall dialysis by a few months.
While conventional anthropometery remained normal, Compliance with dietary therapy involves a major
dual energy x-ray absorptiometry (DEXA) showed a small change in lifestyle and is often difficult. The MDRD
but significant decline in lean body mass and an increase experience is instructive in this regard. The well-screened
in total body fat [59]. and motivated subjects in study B, after receiving inten-
The MDRD study permitted us to evaluate whether sive and ongoing nutritional counseling, could lower
the principles involved in the safe use of LPDs learned their DPI by only 0.1 to 0.2 g/kg/day. It is highly likely
from rigorous, single-center studies could be translated that in clinical practice, the screening will not be as rigor-
into a multicenter research setting. It confirmed the ben- ous, and the patients will not be as motivated and will
eficial effect of a small but significant increase in serum not receive such intensive nutritional counseling. Putting
albumin but failed in one key respect: maintaining an all of these facts together predicts a lower degree of
energy intake of at least 30 kcal/kg/day. In patients en- compliance than achieved in the MDRD study.
rolled in study B, energy intake declined by about 10 to From a public health point of view, it is important to
15% in various groups: from a baseline of 23.3 to 25.9 analyze the incremental resources necessary to achieve
to 20.6 to 22.7 kcal/kg/day [38]. A small but significant a widespread implementation of LPDs. We know that
decline in body weight and transferrin occurred in the almost 50% of incident ESRD patients in the United
first four months of the study, while a gradual, persistent States start RRT without ever having seen a dietitian,
decline occurred in arm muscle area and urine creatinine and only about one third have seen a dietitian on two
excretion over the entire period of follow-up [38]. The or more occasions [11]. Hence, almost 50,000 new pa-
initial steep decline in urine creatinine excretion was tients start RRT in the United States without any super-
expected as a result of a decline in DPI. However, the vision by a dietitian during the pre-ESRD phase. The
slower and sustained decline over the entire period of
precise size of the pre-ESRD pool is unknown, but it
follow-up along with a decline in arm muscle circumfer-
likely to be about a few hundred thousand, and givenence is very suggestive of a small, yet progressive loss
the high prevalence of suboptimal pre-ESRD care, it isof lean body mass. These results are in agreement with
likely that most, if not all, of these patients are neitherthose recently reported by Chauveau et al, which show
evaluated nor counseled by a dietitian. Finally, only athat there occurs a small but progressive loss of lean
small fraction of dietitians likely to be skilled in imple-body mass in patients maintained on LPD [59]. This is
menting LPD—the renal dietitians—spend any signifi-concerning particularly as these patients were very well
cant amount in caring for pre-ESRD patients (Moorescreened for nutritional adequacy and it is probable,
L., personal communication). To be able to introduce aalthough unknown, that upon a longer duration of fol-
LPD successfully as a part of routine care of patientslow-up, clinically as opposed to statistically significant
with advanced renal failure, a large investment in procur-decline in nutritional status may have occurred.
ing renal dietitians will need to be made. Given theIt has been shown repeatedly that when a therapy
strong association between malnutrition induced in thewidely tested in the research setting is introduced on a
pre-ESRD phase and the patient outcome and the highlarge scale in clinical practice, the success rate is usually
prevalence of malnutrition at the time of initiation oflower, and adverse effects are more frequent than pre-
dialysis, nutritional evaluation and interventions remainviously reported. The unsafe levels of energy intake and
important goals of the care of the pre-ESRD patients.the small but significant decline in some nutritional pa-
However, currently, we do not have the resources torameters in the MDRD study are likely to be exagger-
do even this successfully, and it will be important toated outside a research setting, and hence, our repeated
determine whether the small benefit of LPD in slowingconcern regarding the safety of these diets even in young,
progression of renal failure persists in face of ACEInondiabetic patients.
therapy and a similar reassessment of cost-efficacy beDiabetic renal disease. It is well accepted that diabetics
made before we seek to burden the scarce number ofare more vulnerable to malnutrition in face of inade-
renal dietitians with caring for pre-ESRD patients byquate dietary intake. To the best of our knowledge, there
are no studies evaluating the safety of LPDs in older implementing LPDs.
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TIMELY INITIATION OF DIALYSIS tients on LPDs followed by excellent nephrologists.
Moreover, comparisons of mortality are made betweenOthers, as well as ourselves, have argued that the cur-
patients started on dialysis following prolonged LPDs torent practice of initiation of dialysis based on clinical and
the general U.S. ESRD population [64]. These compari-laboratory indices to assess the severity of renal failure is
sons are clearly unfair and inappropriate.flawed [1–5], and the study by Ifudu et al published last
It has also been stated that there is no evidence thatyear supports our belief [60]. Given the fact that a sponta-
initiation of dialysis neither prevents the appearance ofneous decline in DPI occurs with declining renal function
malnutrition nor does it improve the nutritional status[38, 48, 61–63] and this is associated with progressive nutri-
of patients. Again, the high prevalence of malnutritiontional decline [48, 61], our hope is that initiating dialysis
in cross-sectional studies in patients on maintenance dial-proactively once progressive decline in DPI occurs may
ysis is used as evidence against it [8]. We agree that, toprevent this nutritional decline. This forms the basis for
date, there is no evidence that a timely initiation ofour argument that dialysis should be initiated to prevent
dialysis is superior to conservative management in pre-the consequences of uremia, most importantly malnutri-
venting the appearance of malnutrition in patients withtion, rather than to treat established uremia.
advanced renal failure and a spontaneous decline in DPI.Based on the similarity in the relationship of DPI to
However, five studies, four of which were published be-small solute clearances in predialysis patients and pa-
tween 1993 and 1997, have demonstrated the improve-tients on continuous ambulatory peritoneal dialysis
ment in nutritional status in patients initiated on chronic(CAPD) [62], the PD subcommittee of the NKF-DOQI
dialysis [24, 63, 65–67]. Two of these studies involvedsuggested that adequacy targets for CAPD be used as
only patients started on peritoneal dialysis [24, 65], twothe renal function at which dialysis should be instituted,
with patients started on hemodialysis [66, 67], and onethat is, when the renal function declines to below a
studied both group of patients [63]. The latter reportedweekly renal Kt/Vurea of 2.0 [10]. The committee sug-
only 13 patients on peritoneal dialysis, and as this wasgested that dialysis may be delayed if all three of the
significantly lower than the other two, we do not presentfollowing criteria are fulfilled: (1) stable or increasing
those data here. The renal function at the time of initia-edema-free body weight, (2) normalized protein equiva-
tion of dialysis was reported only by one of these studies,lent of nitrogen appearance (nPNA) equal or greater
the CANUSA study, in which patients were started onthan 0.8 g/kg/day, and (3) absence of clinical signs or
dialysis at a weekly renal Kt/Vurea of 0.71 [24]. In thesymptoms attributable to uremia. Using a number of
first study of its kind, Blake et al reported a small butassumptions, a renal weekly Kt/Vurea of 2.0 has been
significant increase in serum albumin over a period ofdeemed to be equal to a GFR of 10.5 mL/min in a patient
12 to 18 months in patients started on peritoneal dialysiswith a total body water of 35 L [10]. It has now been
[65]. The nutritional benefits of starting peritoneal dial-recognized that there is a high rate of discordance be-
ysis were confirmed by the CANUSA study. The initia-tween the various indices used by DOQI (abstracts;
tion of peritoneal dialysis resulted in an increase in DPI,Bueno et al, J Am Soc Nephrol 10:327A, 1999; and Mujais
lean body mass, and subjective global assessment (SGA)et al, J Am Soc Nephrol 10:355A, 1999) and hence, until
[24]. Similarly, initiation of hemodialysis resulted in anoutcome data are available using the various indices, it
increase in DPI [63, 66] and more significantly, also se-is probably appropriate to use only the weekly Kt/Vurea.
rum albumin [66, 67] and serum creatinine [67], againFurthermore, we sense confusion in some about these
indicative of an improvement in nutritional status. Intarget levels. The confusion possibly stems from the use
fact, the magnitude of increase in serum albumin andof the word “early” rather than “timely” in the early
serum creatinine has been quantitated to be 12 to 13%days of this discussion [2, 3]; the former has been inter-
over the first six months of hemodialysis [67].preted as a suggestion that dialysis be started at a GFR
It has also been stated that initiation of dialysis isof 15 to 25 mL/min [8]. We hope that the use of the
likely to result in impairment in the QOL of individuals.word “timely” [4, 5] and reiteration of support for the
However, recent data suggest that even apparently asymp-NKF-DOQI position [10] clarify this confusion.
tomatic patients at creatinine clearance .10 mL/minIt has been argued by some that initiation of dialysis
have significant impairment in QOL [68]. A significantshould be the treatment of last resort in patients with
and sustained improvement in QOL occurs with the initi-advanced renal failure [9]. Moreover, comparisons of the
ation of dialysis [67] (abstract; Mayber et al, Perit Dialhigh mortality rate in the U.S. dialysis population, the
Int 20:S69, 2000), although it remains significantly lowerhigh prevalence of malnutrition, including hypoalbumi-
in patients started on dialysis below a weekly Kt/Vurea ofnemia, and the high prevalence of suboptimal dietary
2.0 (abstract; Korevaar et al, Perit Dial Int 20:S79, 2000).protein and energy intake in maintenance dialysis pa-
This provides additional support for our position abouttients are made with the results achieved in single-center
studies of highly selected and motivated pre-ESRD pa- a timely start.
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Mortality Study Wave 2. Am J Kidney Dis 30(Suppl 1):S67–S85,CONCLUSION
1997
12. Van Biesen Wiedemann N, Lameire N: End-stage renal diseaseDelayed referral, suboptimal pre-ESRD care, and ini-
treatment: A European perspective. J Am Soc Nephrol 9(Suppl):tiation of dialysis at levels far below those recommended
S55–S62, 1998
by DOQI have been confirmed to be widespread prob- 13. Mehrotra R, Lee J, Elivera H, Ahmed Z: Trends in initiation of
dialysis in an urban dialysis clinic in the United States: A long waylems that face the nephrology community. Nonelderly
from Dialysis Outcomes Quality Initiative Guidelines. Adv Peritpatients with advanced nondiabetic renal failure often
Dial 15:138–143, 1999
have a spontaneous decline in DPI to levels of approxi- 14. Arora P, Obrador GT, Ruthazer R, Kausz AT, Meyer KB,
Jenuleson CS, Pereira BJG: Prevalence, predictors, and conse-mately 0.85 g/kg/day, and even in face of intensive nutri-
quences of late nephrology referral at a tertiary care center. J Amtional counseling, they can lower their DPI by only about
Assoc Nephrol 10:1281–1286, 1999
0.1 to 0.2 g/kg/day. The beneficial effect of this small 15. United States Renal Data System: 1999 Annual Data Report.
U.S. Department of Health and Human Services, Public Healthdecline in DPI is unknown, particularly in face of ACEI
Service, National Institutes of Health, Bethesda, 1999and other antiproteinuric therapies. Moreover, institu-
16. Obrador GT, Arora P, Kausz A, Ruthazer R, Pereira BJG,
tion of LPD results in a further lowering of their energy Levey AS: Level of renal function at the initiation of dialysis in
the US end-stage renal disease population. Kidney Int 56:2227–intake, and it is again unknown whether intensive nutri-
2235, 1999tional counseling can result in an increase in energy in-
17. Schmidt RJ, Domico JR, Sorkin MI, Hobbs G: Early referral
takes to safe levels (at least 30 kcal/kg/day but preferably and its impact on emergent first dialyses, health care costs, and
outcome. Am J Kidney Dis 32:278–283, 199835 kcal/kg/day). It is likely that patients will not be as
18. Bonomini V, Feletti C, Scolari MP, Stefoni S: Benefits of earlycarefully selected, nutritional counseling will not be as
initiation of dialysis. Kidney Int 28(Suppl 17):S57–S59, 1985
intensive, and compliance will be lower in the clinical 19. Tattersall J, Greenwood R, Farrington K: Urea kinetics and
when to commence dialysis. Am J Nephrol 15:283–289, 1995setting. There are limited or no data about the efficacy
20. Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJG:or safety of these diets in the presence of advanced renal
Prevalence and factors associated with sub optimal care before
failure in either diabetics (.40% of incident U.S. ESRD initiation of dialysis in the United States. J Am Soc Nephrol
10:1793–1800, 1999patients) or older nondiabetics (approximately 40% of
21. U.S. Renal Data System: Comorbid conditions and correlationsincident U.S. ESRD patients). Initiation of dialysis re- with mortality risk among 3,399 incident hemodialysis patients.
sults in an improvement in both the nutritional status as Am J Kidney Dis 20:32–38, 1992
22. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ:well the QOL of patients and should be considered in
Simple nutritional indicators as independent predictors of mortal-a timely fashion. ity in hemodialysis patients. Am J Kidney Dis 31:997–1006, 1998
23. Hoe TS, Evan LJC, Eng TM, Kee LB: Protein nutrition status of
Reprint requests to Rajnish Mehrotra, M.D., Division of Nephrology adult patients starting chronic ambulatory peritoneal dialysis. Adv
and Hypertension, University of California, Los Angeles, and Harbor- Perit Dial (in press)
UCLA Medical Center, 1000 West Carson Street, Box 406, Torrance, 24. McCusker FX, Teehan BP, Thorpe KE, Keshaviah PR,
California 90509, USA. Churchill DN, The Canada-USA (CANUSA) Peritoneal Dial-
E-mail: rmehrotra@rei.edu ysis Study Group: How much peritoneal dialysis is required for
the maintenance of a good nutritional state? Kidney Int 50(Suppl
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